Glomerulonephropathy

3 papers2 findings

Animals3

Interventions

1

Canagliflozin

downin mice1

1 study

Canagliflozin decreases glomerulonephropathy in mice.
“diminish incidence or severity, in male mice only, of cardiomyopathy, glomerulonephropathy, arteriosclerosis”
Animalsmales
Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice
GeroScience16 Aug 2022

More on Canagliflozin

Upstream

1

CAT

no changein mice1

1 study

CAT has no effect on glomerulonephropathy in mice.
“no effect on hematopoietic neoplasia or glomerulonephropathy”
AnimalsMCAT expression
Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria
The journals of gerontology. Series A, Biological sciences and medical sciences1 Aug 2008

Latest

GeroScience16 Aug

Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice

Experiments in miceCanagliflozin

The Journals of Gerontology, Series A1 Aug

Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria

Experiments in miceInterventions

Experimental Biology and Medicine1 Jan

Effect of long-term somatotropin treatment on body composition and life span in aging obese Zucker rats

Experiments in ratsInterventions

Neurobiology of Aging1 Jan

Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug

Experiments in ratsInterventions